Literature DB >> 24910583

Evaluation of the alamarblue assay for adherent cell irradiation experiments.

Maria A Zachari1, Panagiota S Chondrou1, Stamatia E Pouliliou1, Achilleas G Mitrakas1, Ioannis Abatzoglou1, Christos E Zois1, Michael I Koukourakis1.   

Abstract

The AlamarBlue assay is based on fluorometric detection of metabolic mitochondrial activity of cells. In this study, we determined the methodology for application of the assay to radiation response experiments in 96-well plates. AlamarBlue was added and its reduction measured 7 hours later. Selection of the initial number of plated cells was important so that the number of proliferating cells remains lower than the critical number that produced full AlamarBlue reduction (plateau phase) at the time points of measurements. Culture medium was replaced twice a week to avoid suppression of viability due to nutrient competition and metabolic waste accumulation. There was no need to replace culture medium before adding AlamarBlue. Cell proliferation continued after irradiation and the suppression effect on cell viability was most evident on day 8. At this time point, by comparing measurements from irradiated vs. non-irradiated cells, for various dose levels, a viability dose response curve was plotted. Immediately after the 8(th) day (nadir), cells started to re-grow at a rate inversely related to the radiation dose. By comparing measurements at the time point of nadir vs. a convenient subsequent time point, re-growth dose response abilities were plotted, simulating clonogenic assays.

Entities:  

Keywords:  96-well plate; AlamarBlue; dose response; radiation

Year:  2013        PMID: 24910583      PMCID: PMC4036397          DOI: 10.2203/dose-response.13-024.Koukourakis

Source DB:  PubMed          Journal:  Dose Response        ISSN: 1559-3258            Impact factor:   2.658


  7 in total

1.  Clonogenic assay of cells in vitro.

Authors:  Nicolaas A P Franken; Hans M Rodermond; Jan Stap; Jaap Haveman; Chris van Bree
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

2.  Differential cyclooxygenase-2 enzyme expression in radiosensitive versus radioresistant glioblastoma multiforme cell lines.

Authors:  Aftab Karim; Kevin McCarthy; Ajay Jawahar; Donald Smith; Brian Willis; Anil Nanda
Journal:  Anticancer Res       Date:  2005 Jan-Feb       Impact factor: 2.480

3.  A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity.

Authors:  M M Nociari; A Shalev; P Benias; C Russo
Journal:  J Immunol Methods       Date:  1998-04-15       Impact factor: 2.303

4.  Assessment of the Alamar Blue assay for cellular growth and viability in vitro.

Authors:  G R Nakayama; M C Caton; M P Nova; Z Parandoosh
Journal:  J Immunol Methods       Date:  1997-05-26       Impact factor: 2.303

5.  Establishment and validation of a method for multi-dose irradiation of cells in 96-well microplates.

Authors:  Ioannis Abatzoglou; Christos E Zois; Stamatia Pouliliou; Michael I Koukourakis
Journal:  Biochem Biophys Res Commun       Date:  2013-01-16       Impact factor: 3.575

6.  A new fluorometric assay for cytotoxicity measurements in-vitro.

Authors:  B Page; M Page; C Noel
Journal:  Int J Oncol       Date:  1993-09       Impact factor: 5.650

7.  Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity.

Authors:  J O'Brien; I Wilson; T Orton; F Pognan
Journal:  Eur J Biochem       Date:  2000-09
  7 in total
  17 in total

1.  Assessment of Radiobiological α/β Ratio in Lung Cancer and Fibroblast Cell Lines Using Viability Assays.

Authors:  Ilias V Karagounis; Eleni K Skourti; Maria V Liousia; Michael I Koukourakis
Journal:  In Vivo       Date:  2017 Mar-Apr       Impact factor: 2.155

2.  Indocyanine green-mediated photobiomodulation on human osteoblast cells.

Authors:  Gamze Bölükbaşı Ateş; Ayşe Ak; Bora Garipcan; Murat Gülsoy
Journal:  Lasers Med Sci       Date:  2018-05-09       Impact factor: 3.161

3.  Apalutamide radio-sensitisation of prostate cancer.

Authors:  Christos Kakouratos; Dimitra Kalamida; Ioannis Lamprou; Erasmia Xanthopoulou; Christos Nanos; Alexandra Giatromanolaki; Michael I Koukourakis
Journal:  Br J Cancer       Date:  2021-09-01       Impact factor: 9.075

4.  Fever-range hyperthermia vs. hypothermia effect on cancer cell viability, proliferation and HSP90 expression.

Authors:  Dimitra Kalamida; Ilias V Karagounis; Achilleas Mitrakas; Sofia Kalamida; Alexandra Giatromanolaki; Michael I Koukourakis
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

5.  Lactate dehydrogenase 5 isoenzyme overexpression defines resistance of prostate cancer to radiotherapy.

Authors:  M I Koukourakis; A Giatromanolaki; M Panteliadou; S E Pouliliou; P S Chondrou; S Mavropoulou; E Sivridis
Journal:  Br J Cancer       Date:  2014-04-08       Impact factor: 7.640

6.  Disulfiram anti-cancer efficacy without copper overload is enhanced by extracellular H2O2 generation: antagonism by tetrathiomolybdate.

Authors:  Ali Calderon-Aparicio; Mary Strasberg-Rieber; Manuel Rieber
Journal:  Oncotarget       Date:  2015-10-06

7.  The Effect of Antimicrobial Peptides on the Viability of Human Corneal Epithelial Cells.

Authors:  Ezgi Ulkuseven; David J McCanna; Lakshman N Subbaraman; Lyndon W Jones
Journal:  Probiotics Antimicrob Proteins       Date:  2021-04       Impact factor: 4.609

8.  Important role of autophagy in endothelial cell response to ionizing radiation.

Authors:  Dimitra Kalamida; Ilias V Karagounis; Alexandra Giatromanolaki; Michael I Koukourakis
Journal:  PLoS One       Date:  2014-07-10       Impact factor: 3.240

9.  Repression of the autophagic response sensitises lung cancer cells to radiation and chemotherapy.

Authors:  Ilias V Karagounis; Dimitra Kalamida; Achilleas Mitrakas; Stamatia Pouliliou; Maria V Liousia; Alexandra Giatromanolaki; Michael I Koukourakis
Journal:  Br J Cancer       Date:  2016-07-05       Impact factor: 7.640

10.  Inhibition of IKK-NFκB pathway sensitizes lung cancer cell lines to radiation.

Authors:  Avgi Tsolou; Maria Liousia; Dimitra Kalamida; Stamatia Pouliliou; Alexandra Giatromanolaki; Michael Koukourakis
Journal:  Cancer Biol Med       Date:  2017-08       Impact factor: 4.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.